Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

52.62
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
46.43
Today|||52-Week Range
63.40
-5.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.1B

Company Description

Alkermes Plc operates as a biopharmaceutical company. It engages in the development, manufacture, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include the brands Aristada and Vivitrol. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin D04 C5Y6
P:(531) 772-8000
Investor Relations:
(781) 609-6377

Employees

Shareholders

Mutual fund holders73.21%
Other institutional30.22%
Individual stakeholders1.07%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane M. CookePresident
Declan O'ConnorSenior Vice President-Operations
Jim FratesChief Financial Officer & Senior Vice President
Elliot W. EhrichExecutive Vice President-Research &Development